Eagle Pharmaceuticals - 53 Year Dividend History | EGRX
Historical dividend payout and yield for Eagle Pharmaceuticals (EGRX) since 1971. The current TTM dividend payout for Eagle Pharmaceuticals (EGRX) as of October 11, 2024 is $0.00. The current dividend yield for Eagle Pharmaceuticals as of October 11, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Products Manufacturing |
$0.010B |
$0.317B |
|
Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101, EP-3102, Ryanodex and EP-4104. Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
